CN Patent

CN101360751A — 氧连接的嘧啶衍生物

Assigned to CTI BIOLOGICAL MEDICAL Inc · Expires 2009-02-04 · 17y expired

What this patent protects

本发明涉及可用作抗增生剂的嘧啶化合物。更具体地说，本发明涉及氧连接并经取代的嘧啶化合物、其制备方法、含有这些化合物的药物组合物和这些化合物在治疗增生性疾病中的用途。这些化合物可用作治疗许多包括肿瘤和癌症等增生性疾病以及与激酶相关的其它疾病或病症的药剂。

USPTO Abstract

本发明涉及可用作抗增生剂的嘧啶化合物。更具体地说，本发明涉及氧连接并经取代的嘧啶化合物、其制备方法、含有这些化合物的药物组合物和这些化合物在治疗增生性疾病中的用途。这些化合物可用作治疗许多包括肿瘤和癌症等增生性疾病以及与激酶相关的其它疾病或病症的药剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN101360751A
Jurisdiction
CN
Classification
—
Expires
2009-02-04
Drug substance claim
No
Drug product claim
No
Assignee
CTI BIOLOGICAL MEDICAL Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.